作者

Matthew Royle, Ph.D.

合伙人

Read More

Adrian Toutoungi

合伙人

Read More

Paul England, DPhil

高级专业支持律师

Read More
作者

Matthew Royle, Ph.D.

合伙人

Read More

Adrian Toutoungi

合伙人

Read More

Paul England, DPhil

高级专业支持律师

Read More

2020年7月27日 | 39:23

Dissecting the Regeneron v Kymab mouse case – what it says and its impact on patents

The Supreme Court's Regeneron Pharmaceuticals Inc v Kymab Ltd decision to revoke two patents for transgenic mouse technology has caused concern to biotech patent owners, especially since the Supreme Court expressed a need to rebalance patent law.

Has this case shifted the boundaries of patent protection, or merely clarified the status quo? What is its context, and broader impact on patents both within and outside the life sciences technology area?

Our experts explain the case and answer these questions in this webinar.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

酒店与休闲

One Nucleus Genesis Digital 2020 – Key takeaways from our cell and gene therapy panel session

2021年1月6日
Quick read

作者 Adrian Toutoungi

点击此处了解更多
pills
专利与创新

IP: Licensing and insolvency

2020年7月23日
QUICK READ

作者

点击此处了解更多
woman-with-scientific-model
酒店与休闲

Everything biologic and biosimilar in-house counsel need to know about COVID-19

2020年4月29日

作者

点击此处了解更多

相关活动